2975-41-9 | 2-Aminoindan

Availability
Typically In Stock

Description

• Catalog Number: AB38852
• Chemical Name: 2-Aminoindan
• CAS Number: 2975-41-9
• Molecular Formula: C9H11N
• Molecular Weight: 133.1903
• MDL Number: MFCD00082597
• SMILES: NC1Cc2c(C1)cccc2

Computed Properties

• Complexity: 108
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 10
• Hydrogen Bond Acceptor Count: 1
• Hydrogen Bond Donor Count: 1
• XLogP3: 1.7

Literature

• Pharmacokinetic and pharmacodynamic evaluation of 5-methoxy-2-aminoindane (MEAI): A new binge-mitigating agent.

  Toxicology and applied pharmacology 20180315

• Analgesic and anti-nociceptive activity of hydroethanolic extract of Drymaria cordata Willd.

  Indian journal of pharmacology 20110401

• Experimental evaluation of antipyretic and analgesic activity of aspartame.

  Indian journal of pharmacology 20110201

• Effects of rasagiline, its metabolite aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro.

  BMC pharmacology 20110101

• Aminoindanes--the next wave of 'legal highs'?

  Drug testing and analysis 20110101

• The identification of indacaterol as an ultralong-acting inhaled beta2-adrenoceptor agonist.

  Journal of medicinal chemistry 20100513

• The neuroprotective mechanism of 1-(R)-aminoindan, the major metabolite of the anti-parkinsonian drug rasagiline.

  Journal of neurochemistry 20100301

• Analgesic and anti-inflammatory activity of amifostine, DRDE-07, and their analogs, in mice.

  Indian journal of pharmacology 20100201

• Analgesic effect of Lepidium sativum Linn. (Chandrashura) in experimental animals.

  Ayu 20100101

• Synthesis and pharmacological evaluation of schiff bases of 4-(2-aminophenyl)-morpholines.

  Indian journal of pharmaceutical sciences 20090101

• [Analysis of designer drugs detected in the products purchased in fiscal year 2006].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20081001

• Synthesis, dopaminergic profile, and molecular dynamics calculations of N-aralkyl substituted 2-aminoindans.

  Bioorganic & medicinal chemistry 20080315

• Indantadol, a novel NMDA antagonist and nonselective MAO inhibitor for the potential treatment of neuropathic pain.

  IDrugs : the investigational drugs journal 20070901

• Conformations of 2-aminoindan in a supersonic jet: the role of intramolecular N-H...pi hydrogen bonding.

  The journal of physical chemistry. A 20070712

• Steady-state pharmacokinetics and pharmacodynamics of CHF3381, a novel antineuropathic pain agent, in healthy subjects.

  British journal of clinical pharmacology 20050401

• Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties.

  Bioorganic & medicinal chemistry letters 20041206

• Safety, pharmacokinetics, and pharmacodynamics of CHF 3381, a novel N-methyl-D-aspartate antagonist, after single oral doses in healthy subjects.

  Journal of clinical pharmacology 20030801

• Copper-containing monooxygenases: enzymatic and biomimetic studies of the O-atom transfer catalysis.

  Journal of biotechnology 20020401